{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "42227-081",
      "generic_name": "HUMAN C1-ESTERASE INHIBITOR",
      "labeler_name": "Takeda Pharmaceuticals America, Inc.",
      "brand_name": "Cinryze",
      "active_ingredients": [
        {
          "name": "HUMAN C1-ESTERASE INHIBITOR",
          "strength": "500 [iU]/5mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "42227-081-01",
          "description": "5 mL in 1 VIAL, SINGLE-USE (42227-081-01)",
          "marketing_start_date": "20081201",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {},
      "marketing_category": "BLA",
      "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
      "spl_id": "421ea216-278f-4ca8-ae5d-5dafe85658a0",
      "product_type": "PLASMA DERIVATIVE",
      "route": [
        "INTRAVENOUS"
      ],
      "marketing_start_date": "20081201",
      "product_id": "42227-081_421ea216-278f-4ca8-ae5d-5dafe85658a0",
      "application_number": "BLA125267",
      "brand_name_base": "Cinryze",
      "pharm_class": [
        "Decreased Vascular Permeability [PE]",
        "Human C1 Esterase Inhibitor [EPC]",
        "Kallikrein Inhibitors [MoA]"
      ]
    }
  ]
}